Investments News

Exeters' company SENISCA raises £2 million to treat age-related chronic diseases

University of Exeter - 09-Jun-2022

Funding might allow RNA-based rejuvenation tech to enter ex vivo lab tests

Hevolution Foundation to spend $1 billion annually on the biology of aging

MIT Technology Review - 07-Jun-2022

Considering funding a $100 million age reversal X Prize and the TAME(metformin) trial

Insilico Medicine series D funding to grow its pipeline and create an AI-driven robotic drug discovery laboratory

Longevity Technology - 06-Jun-2022

Big data combined with laboratory automation - the pace of drug discovery is about to take off!

Selah Therapeutics launched to focus on ketone-based therapies for heart disease

Longevity Technology - 13-May-2022

Treatment options for diseases of aging - from the makers of metabolic switch

New longevity startup MitoRx Therapeutics is developing mitochondria protective drugs

Longevity Technology - 25-Apr-2022

Targeting age-related diseases, the company's pre-clinical compounds to progress to the clinic

CARMAT raised €40.5 million - set to resume the artificial heart production

Longevity Technology - 21-Apr-2022

Aeson could prolong lives of patients awaiting a human heart transplant

Satellite Bio raised $110M to push its tissue therapies to the clinic

FierceBiotech - 20-Apr-2022

Bioengineered implanatable tissues can repair or replace diseases organs

YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO

CISION PR Newswire - 14-Apr-2022

Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line

Turn Bio raised funds to usher epigenetic reprogramming from bench to bedside

Biospace - 11-Apr-2022

mRNA technology-reset aging to extend health span and improve quality of life

Elastrin Therapeutics secures $10 million of funding for its calcification removal platform

Forever Healthy Foundation - 07-Apr-2022

Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications

Retro Biosciences launched to add 10 years to human lifespan

Biospace - 06-Apr-2022

$180M fund will support research on cellular reprogramming, autophagy & plasma-inspired therapeutics

Revel pharmaceutics raised $8.4M to push enzyme therapies to clinic

KIZOO Technology Ventures - 17-Mar-2022

Funds will be used to develop enzymes that repair collagen and reverse ageing or disease

Tornado, new longevity biotech developing safer and effective mTOR inhibitors

Longevity Technology - 03-Mar-2022

Different flavours of rapalogs targeting different age-related conditions

Maximon announces 50,000 CHF (approx. £40K) Longevity Prize for Translational Research

Maximon - 01-Mar-2022

And by longevity it means "substantially increase health span or life span" - apply now!

Synchron gets investment from Neuralink cofounder

Futurism - 07-Feb-2022

Appears to be ahead in the race as already started human trials

Hair grown from your own cells may treat baldness

New Atlas - 06-Feb-2022

dNovo converts any cell to hair stem cells, and have already grown hair in mice

Arda Therapeutics, new biotech startup aims to delay or reverse disease progression

Lifespan.io (LEAF) - 28-Jan-2022

Tailoring strategies to eliminate bad cells in age-related diseases

Cellino Biotech raises $80m to upscale its automated stem cell production

TechCrunch - 25-Jan-2022

Fast, cheap and plentiful iPSCs will be needed for clinical trials and new treatments

Altos Labs comes out of stealth with $3 billion of capital

Genetic Engineering & Biotechnology News (GEN) - 19-Jan-2022

Huge backing that cellular reprogramming can have a significant impact on health and ageing

StarkAge receives 2 million euros to design safer senescence-targeted therapies

Longevity Technology - 19-Jan-2022

Funding will ensure the development of a new immunotherapy for age-related diseases

DKG profile interview with its own Remus Stanescu, Director of Longevity Financial Advisors

Deep Knowledge Group - 12-Jan-2022

Highlights some nuances when investing in the longevity industry

Genflow IPO listing: the first longevity firm to debut on London Stock Exchange

Longevity Technology - 10-Jan-2022

Seeking funds to develop gene therapies that target ageing in humans and dogs

Life Biosciences raises funding to develop innovative therapies against ageing biology

Longevity Technology - 06-Jan-2022

Invests $82 million in research platforms, aiming to prevent or reverse age-related diseases

NewLimit, a new biotech launches to slowdown or reverse ageing

NewLimit - 12-Dec-2021

Aims to extend healthspan and cure ageing with affordable epigenetic therapies

Spring discovery to prevent diseases by developing treatments for ageing

Medium - 11-Dec-2021

Raised $18 million Series A funding to speed up ageing research